Matthew C Sophy, DO | |
73 Coal St, Port Carbon, PA 17965-1823 | |
(570) 622-6302 | |
(570) 622-7153 |
Full Name | Matthew C Sophy |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 42 Years |
Location | 73 Coal St, Port Carbon, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922071620 | NPI | - | NPPES |
0009455300002 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207QA0505X | Family Medicine - Adult Medicine | OS005079L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Schuylkill Medical Center - South Jackson Street | Pottsville, PA | Hospital |
St Luke's Miners Memorial Hospital | Coaldale, PA | Hospital |
Geisinger St. Luke's Hospital | Orwigsburg, PA | Hospital |
Mailing Address | Practice Location Address |
---|---|
Matthew C Sophy, DO 73 Coal St, Port Carbon, PA 17965-1823 Ph: (570) 622-6302 | Matthew C Sophy, DO 73 Coal St, Port Carbon, PA 17965-1823 Ph: (570) 622-6302 |
News Archive
Mirna Therapeutics announced today that the Company received a $5 million award from the State of Texas through the Texas Emerging Technology Fund ("ETF"). The ETF was created with the goal of growing new and existing businesses to accelerate the introduction of new products and services in the marketplace. This is the largest award of this type that has ever been granted.
A new report released today by Business Roundtable, an association of chief executive officers of leading U.S. companies, finds that annual per employee health care costs will triple to nearly $29,000 over the next decade without significant marketplace reforms that reduce costs, expand coverage and improve delivery.
Compelling evidence that herbs and spices found prevalent in many popular dishes can help ward off disease remains elusive but, according to the latest issue of Food Technology magazine, some small clinical trials raise the question of whether some positive health influence exists.
In what appears to be a disappointing outcome, trials of a new gel designed for women to protect themselves from the AIDS virus were stopped this week when researchers found that women using it became infected at a higher rate than women not using it.
› Verified 3 days ago